Sphingolipids are essential components of eukaryotic membranes, and many unicellular eukaryotes, including kinetoplastid protozoa, are thought to synthesize exclusively inositol phosphorylceramide (IPC). Here we characterize sphingolipids from Trypanosoma brucei, and a trypanosome sphingolipid synthase gene family (TbSLS1-4) that is orthologous to Leishmania IPC synthase. Procyclic trypanosomes contain IPC, but also sphingomyelin, while surprisingly bloodstream-stage parasites contain sphingomyelin and ethanolamine phosphorylceramide (EPC), but no detectable IPC. In vivo fluorescent ceramide labelling confirmed stage-specific biosynthesis of both sphingomyelin and IPC. Expression of TbSLS4 in Leishmania resulted in production of sphingomyelin and EPC suggesting that the TbSLS gene family has bi-functional synthase activity. RNAi silencing of TbSLS1-4 in bloodstream trypanosomes led to rapid growth arrest and eventual cell death. Ceramide levels were increased more than threefold by silencing suggesting a toxic downstream effect mediated by this potent intracellular messenger. Topology predictions support a revised six-transmembrane domain model for the kinetoplastid sphingolipid synthases consistent with the proposed mammalian sphingomyelin synthase structure. This work reveals novel diversity and regulation in sphingolipid metabolism in this important group of human parasites.
Introduction
The order Kinetoplastida comprises a phylogenetically ancient group of protozoa, many of which cause significant human and veterinary diseases. These include African trypanosomes of the Trypanosoma brucei (ssp.) group, which cause African Sleeping Sickness, the South American trypanosome Trypanosoma cruzi, which causes Chaga's disease, and multiple Leishmania species, which cause a spectrum of diseases worldwide. These parasites all have complex life cycles that alternate between an insect vector and the mammalian host. And in each case they elaborate unique sets of cell surface glycoproteins and/or glycolipids that form essential surface coats for survival in their various hosts (Ferguson, 1999) . Many of these glycoconjugates are attached via glycosylphosphatidylinositol (GPI) anchors.
Considerable evidence exists in other systems for interplay of GPI structures with specific classes of lipids, in particular sterols and sphingolipids (reviewed in Schuck and Simons, 2006) . In polarized mammalian epithelial cells post-Golgi sorting is strongly influenced by GPI anchors, which associate with sphingolipid/cholesterolrich membrane lipid rafts. In yeast exit of GPI-anchored proteins from the endoplasmic reticulum (ER) is dependent on de novo synthesis of ceramide (Sutterlin et al., 1997) , and this sorting is influenced by sphingolipid-and ergosterol-rich lipid rafts (Bagnat et al., 2000) . This phenomenon is not found in trypanosomes or mammals (Sutterwala et al., 2007) . Nevertheless, GPI anchors do strongly influence trafficking within the secretory and endocytic pathways in trypanosomes (Engstler et al., 2004; Schwartz and Bangs, 2006) , but the extent to which lipid rafts might influence GPI-dependent trafficking in trypanosomes is unclear. The major GPI-anchored cargo in bloodstream-stage African trypanosomes is the variant surface glycoprotein (VSG), which is an abundant surface protein. Conflicting data have been presented concerning the presence of VSG in detergent-resistant membranes (Nolan et al., 2000; Denny et al., 2001 ), although such rafts are known to exist in Leishmania (Ralton et al., 2002; Zuffrey et al., 2003; Denny and Smith, 2004) . Inhibition of sphingoid base synthesis, the initial step in the sphingolipid pathway, has no effect on transport of VSG to the cell surface (Sutterwala et al., 2007) , but sphingoid base synthesis is essential for viability and the question remains whether the critical requirement is for subsequent synthesis of ceramide and/or higher-order sphingolipids. In contrast, Leishmania promastigotes do not require de novo sphingolipid synthesis, instead using this pathway mainly for ethanolamine synthesis .
The major higher-order sphingolipid species in mammals is sphingomyelin (SM: choline phosphorylceramide), and in yeast is inositol phosphorylceramide (IPC) . Recently much progress has been achieved in elucidating these biosynthetic pathways (Futerman and Riezman, 2005; Tafesse et al., 2006) . In each case the initial steps in sphingolipid synthesis leading to ceramide take place in the ER. Ceramide is then transported to the Golgi where polar head groups are transferred from phospholipids donors, phosphorylcholine from phosphatidylcholine (PC) to make SM, and phosphorylinositol from phosphatidylinositol (PI) to make IPC. Two mammalian sphingomyelin synthases (SMS) have been identified by expressioncloning strategies, SMS1 located in the Golgi and SMS2 located in the plasma membrane Yamaoka et al., 2004) . Similarly, inositol phosphorylceramide synthase (IPCS) is found in the Golgi of Saccharomyces cerevisiae (Levine et al., 2000) .
The sphingolipid content and biosynthetic capabilities of parasitic protozoa have drawn attention due to the potential for new chemotherapeutic targets. Among the kinetoplastid parasites T. cruzi and Leishmania both synthesize IPC (Kaneshiro et al., 1986; Bertello et al., 1995; Uhrig et al., 1996) , comprising nearly 10% of all membrane phospholipids in Leishmania (Zhang et al., 2005) , and it has been generally assumed that all kinetoplastids favour IPC synthesis (Denny and Smith, 2004; Heung et al., 2006; Sonda and Hehl, 2006) . Procyclic-stage T. brucei do contain IPC (Güther et al., 2006; Fridberg et al., 2008) , but earlier compositional analyses also suggested the presence of SM in both bloodstream and procyclic stage parasites (Patnaik et al., 1993) .
In this work we characterize a family of sphingolipid synthase (TbSLS) genes in T. brucei, and perform detailed analyses of sphingolipids from both stages of the parasite life cycle. Contrary to expectations, we find IPC only in procyclic parasites, and surprisingly that SM is synthesized by both life cycle stages. In addition, the unusual sphingolipid ethanolamine phosphorylceramide (EPC) also is found in bloodstream cells. TbSLS4 is localized to the Golgi, and when expressed transgenically in Leishmania mediates the synthesis of both SM and EPC, suggesting that it has bi-functional activity. RNAi silencing of the TbSLS locus leads to elevated ceramide levels and growth arrest indicating that synthesis of higher-order phosphosphingolipids is essential in trypanosomes. Modelling suggests that the related kinetoplastid SLS family is more similar to mammalian SM synthases than previously proposed . These results reveal unexpected diversity and novel regulation in sphingolipid metabolism in kinetoplastid protozoa.
Results

Organization of the TbSLS locus
Querying the T. brucei genome (http://www.sanger.ac.uk/ Projects/T_brucei/) (Berriman et al., 2005) with the human sphingomyelin synthase 2 protein sequence (SMS2, Accession No. Q8NHU3) identified a set of four tandemly linked genes (Tb09.211.1030-Tb09.211.1000) with BLASTP values ranging from 2.4e-16 to 5.4e-20. These genes were also recognized as orthologues of a Leishmania major IPC synthase (LmjIPCS, LmjF35.4990) gene , and occupy syntenic sites on chromosomes 9 and 35, respectively, of T. brucei and L. major. Hereafter we refer to the trypanosomal genes as TbSLS1-4 (Fig. 1A) . The nucleotide sequences are highly similar extending well into the 5′ upstream regions of all but the 5′ open reading frame (orf) (TbSLS1). There are several differences in the 5′ regions of the TbSLS orfs relative to the previous description of . ). Collectively these data provide a more current view of the TbSLS gene family. The four deduced proteins are highly similar throughout (84.9-90.5% amino acid identity), with most of the sequence divergence at the extreme C-terminus (Fig. S1A) , and all are predicted to have sixtransmembrane (TM) domains (see below, Fig. 9 ), consistent with the proposed membrane topology for human SMS2 . regulated. To study the role of these genes in trypanosomal sphingolipid metabolism we used a common 757 nt internal coding sequence to generate a clonal BSF cell line containing an inducible pan-specific dsRNA construct targeting the four-gene TbSLS locus (Fig. 1A) . Northern blot analysis of total RNA from induced and control parasites revealed that TbSLS transcripts were reduced~50% following 24 h of TbSLS dsRNA expression (Fig. 2B) . Despite the modest reduction in transcript levels the effect on BSF cell viability was dramatic. Uninduced cells grew with normal kinetics throughout the 4-day culture period, but growth of the induced cells was greatly impaired after 8 h (Fig. 2C) . By 24 h of dsRNA induction all growth ceased and cellular morphology was significantly disrupted (Fig. 2D ). Cells were arrested in division but replication of DNA and organelles continued giving rise to cells containing multiple nuclei, kinetoplasts and flagella. After 48 h of induction some cell death was apparent and the gross morphology of live cells was even more aberrant (not shown). These results indicate that the TbSLS gene products are required for cell viability. Likely explanations for growth arrest of TbSLS-ablated cells are discussed below.
Sphingolipid profiles of normal and TbSLS-silenced trypanosomes
In order to determine the effect of pan-TbSLS ablation on cellular sphingolipid composition, we examined cells at Յ 24 h of induction of silencing, before significant death occurred, and performed total lipid analyses on BSF and PCF samples using ESI mass spectrometry (Fig. 3, Table 1 ). Both dihydroceramide (d18:0/16:0, m/z 538.8) and ceramide (d18:1/16:0, m/z 536.8) were observed in normal BSF and PCF lipids. However the ratio of these two species was consistently reversed in a stage-specific manner with ceramide more prominent in BSF (Fig. 3A) and dihydroceramide more prominent in PCF (Fig. 3C ). PCF contained two higher-order sphingolipid species seen at m/z 727.8 in positive-ion scans (Fig. 3D) , representing a sodiated d18:0/16:0 SM ion, and at m/z 780.7 in negative ion scans (Fig. 3C ) representing a deprotonated d18:0/16:0 IPC ion. Additional minor IPC species were also seen in negative ion scans of total procyclic lipids extracted in chloroform : methanol : water (CMW) 10:10:3 (see Fig. S2A ). In contrast, the major higher-order sphingolipid species in BSF A. The organization of the~9 kb TbSLS locus on Chromosome 9 is presented schematically from the 5′ end of the upstream intergenic region to the 3′ end of the downstream intergenic region (to scale). Black boxes, TbSLS1-4 genomic open reading frames (orfs) from first in-frame Met codons. Grey boxes, extent of highly similar 5′ UTRs. Arrowhead over TbSLS4 indicates the site of in situ in-frame introduction of the HA epitope tag. The thin bar over the TbSLS1 orf represents the relative position of the 757 nt dsRNA target sequence. The thick bar under the TbSLS1 orf represents the relative position of the 283 nt target sequence of the northern probe. Pair-wise nucleotide sequence identities of the RNAi target regions range from 87.3% (TbSLS1 versus TbSLS2) to 98.9% (TbSLS3 versus TbSLS4). Note that the numbering of the TbSLS genes is consecutive and does not match the numbering of . B. The deduced N-terminal amino acid sequences of the TbSLS orfs. Numbering is relative to the first in-frame methionine residue downstream of the experimentally determined trans-splice acceptor site in the corresponding mRNAs (arrowhead). All sequences are aligned to the first methionine codon ) of the genomic TbSLS1 orf. Identity is indicated by dots, and the positions of 5′ stop codons in the TbSLS2 and TbSLS3 genomic orfs are indicated by asterisks (codon -15). The initiator methionine codons for each orf as originally annotated in the T. brucei genomic database (http://www.sanger.ac.uk/Projects/T_brucei/) (Berriman et al., 2005) are underlined. As defined in Fig. 9A and Fig. S1 , the beginning of the first transmembrane domain (TM1) is indicated below the alignment.
trypanosomes was SM, seen in positive-ion scans as a mixture of protonated (m/z 703.7 and 705.5) and sodiated (m/z 725.8 and 727.8) ions representing d18:1/16:0 and d18:0/16:0 SM (Fig. 3B) . Additionally, a minor species confirmed as EPC (m/z 659.6) was consistently observed in negative ion scans (Fig. 3A) . In all cases these sphingolipids were assembled on ceramide anchors reflecting the predominant stage-specific precursor pool, i.e. ceramide (d18:1/16:0) in BSF and dihydroceramide (d18:0/16:0) in PCF. Surprisingly, no IPC was observed in negative ion scans of bloodstream cells (Fig. 3A) , and this absence was confirmed in equivalent scans of CMW 10:10:3 extracts (Fig. S2B) .
Silencing of the TbSLS locus in BSF trypanosomes led to a 3.5-fold increase in the ceramide precursor pool, as would be expected if synthesis of higher-order sphingolipids is impaired (Fig. 4 and Fig. S3 ), but no changes were seen in the levels of endogenous EPC or SM (positive-ion scans not shown), perhaps because turnover of these end-products is very low in non-dividing cells. In these experiments we frequently observed global increases (1.6-to 1.9-fold) of other non-sphingolipids. However, careful estimation of the abundance of selected representative phosphoglycerol lipid species confirms that the fold increases are consistently and significantly less (P < 0.04) than the increases seen for ceramide (Fig. S3) . These results strongly suggest that one or more of the TbSLS gene products have sphingolipid synthase activity. Con- 
SM synthesis in trypanosomes
To investigate sphingolipid biosynthesis both PCF and BSF parasites were metabolically labelled with the fluorescent ceramide analogue NBD-ceramide (NBD-Cer, Fig. 5A ). BSF parasites converted NBD-Cer in a temperature/time-dependent manner to an end-product having the same mobility as authentic NBD-SM (lanes 1 versus 5, R f~0.18). Treatment with sphingomyelinase consumed this species and regenerated the original NBD-Cer substrate confirming the product as NBD-SM (Fig. 5B , lanes 1 versus 2). An unidentified end-product was also seen in bloodstream cells (Fig. 5A, lane 5, Rf 0.28, asterisk) . This is unlikely to be the sphingolipid X species previously detected by [ 3 H]-serine labelling as that lipid consistently migrated closely with authentic SM in two solvent systems (Sutterwala et al., 2007) . Glycosylceramides have been reported in African trypanosomes (Uemura et al., 2006) and the unidentified sphingolipid may be one of these, although it did not co-migrate with either the NBD-GalCer or the NBD-LacCer standards. Alternatively it may be NBD-EPC, consistent with the low levels of this sphingolipid in BSF lipid profiles (Fig. 3) . NBD-SM was also detected as a less abundant species in PCF lipids that co-migrated with authentic standard (Fig. 5A , lane 3), and was consumed by sphingomyelinase (data not shown). Another NBD-labelled species in PCF cells with a slightly faster mobility (R f~0.20) was confirmed as NBD-IPC based on sensitivity to bacterial PI-specific phospholipase C (PI-PLC, Fig. 5B , lanes 3 versus 4) (Bertello et al., 2000) , and co-migration with NBD-IPC standard generated in vitro with membranes from transgenic BSF parasites expressing LmjIPCS (not shown, see also Fig. 5D ). Finally, an unidentified high-mobility product was detected in both PCF and BSF trypanosomes (Fig. 5A , lanes 2-5, hash, Rf~0.82). The identity of this species is uncertain but its mobility suggests that it is closely related to the NBD-Cer substrate.
We also tested the effect of TbSLS RNAi on in vivo synthesis of NBD-SM, but no obvious decrease in synthesis was seen (data not shown), most likely because of the insensitivity of this assay to the modest knockdown of TbSLS expression at 24 h of silencing. Nevertheless, these results confirm that both stages of the trypanosome life cycle are capable of de novo synthesis of higher-order sphingolipids, and that the major species synthesized in each stage of the life cycle are consistent with the respective steady-state sphingolipid compositions.
Biosynthetic activity of transgenic TbSLS4 and LmjIPCS
We exploited the fact that Leishmania synthesize IPC, but not SM or EPC, as a platform to assay the biosynthetic activity of the TbSLS family. The TbSLS4 orf was constitutively expressed in cultured promastigote forms of L. major ( Fig. 5C ) and in vivo incorporation of NBD-Cer was assessed. Control promastigotes synthesized an NBD-Cer-labelled product (lane 2) that co-migrated with both NBD-IPC standard and NBD-IPC synthesized by PCF trypanosomes (data not shown). In contrast, transformed promastigotes expressing TbSLS4 synthesized an additional species (lane 4) that co-migrated with NBD-SM standard and with NBD-SM synthesized by PCF trypanosomes (data not shown). This species was completely consumed by treatment with sphingomyelinase (data not shown). Mass spectrometry analyses of total lipids derived from this cell line revealed abundant d16:1/ 18:0 SM (H + and Na + ions of m/z 703 and 725) in positiveion scans, confirming the SM synthase activity of the TbSLS4 gene product (Table 1) . A signal was also seen for d16:1/18:0 EPC (m/z 660) in negative ion scans suggesting that TbSLS4 has bi-functional synthetic activity. Conversely, we used the absence of IPC in BSF trypanosomes to confirm the IPC synthase activity of LmjIPCS by constitutive expression in cultured BSF cells. This cell line synthesized an NBD-Cer-labelled species that co-migrated with in vivo labelled Leishmania NBD-IPC (Fig. 5D , lanes 2 versus 4), and that was consumed by PI-PLC treatment (data not shown). In addition, an in vitro synthesis assay programmed with membranes from this cell line had IPC synthase activity elevated~300-fold over background in control BSF cells (Fig. S4 ). Collectively these results prove that the TbSLS gene family has SM and EPC synthase activity, in contrast to the orthologous Leishmania enzyme, which is a true IPC synthase.
TbSLS localization
In both yeast and mammalian cells, sphingolipid synthases are located in the Golgi apparatus (Levine et al., 2000; Tafesse et al., 2006) . In trypanosomes the Golgi is located between the central nucleus and the posterior flagellar pocket (Vickerman, 1969; He et al., 2004) . To localize the trypanosomal enzymes we created a tagged BSF cell line in which the HA tag was fused to the C-terminus of the TbSLS4 gene product by in situ homologous recombination into one allele of the TbSLS locus (see Fig. 1A ). This strategy relies on endogenous readthrough transcription for more physiological expression levels thereby minimizing the potential for mislocalization of the tagged protein associated with the more common strategy of ectopic overexpression. Expression in the reporter cell line of a tagged protein (~40 kDa) was confirmed by immunoprecipitation with anti-HA antibodies (data not shown). Fixed permeablized cells were co-stained with anti-HA antibody and antibodies to either the ER marker BiP (Bangs et al., 1993) , or the lysosomal membrane marker, p67 . Consistent with Golgi localization TbSLS4:HA typically presented as one or two clusters in the post-nuclear region distinct from both the ER network ( Fig. 6A-D) and the single terminal lysosome (Fig. 6E-H) . To confirm these structures as the Golgi we in situ Ty-tagged an endogenous Golgi marker enzyme in the TbSLS4:HA cell line thereby allowing simultaneous immunolocalization of the HAand Ty-tagged gene products. The target Golgi gene (Tb927.7.300) has been tentatively identified as a b-Nacetylglucosaminyl transferase (TbGT15, M. Ferguson, University of Dundee, pers. comm.). In the representative A-H. Fixed and permeablized BSF cells expressing TbSLS4:HA were stained with anti-HA to detect TbSLS4 localization (green) and either anti-BiP (A-D) or anti-p67 (E-H) to detect the ER or lysosome respectively (red). Arrowheads indicate TbSLS4:HA-positive clusters (C and G). I-L. Fixed permeabilized cells expressing both TbSLS4:HA and TbGT15:Ty were stained with anti-HA (green) and anti-TY (red) to detect TbSLS4 and TbGT15 respectively. Arrowheads indicate prominent colocalization (L, yellow). In all panels, cells were co-stained with DAPI (blue) to visualize the kinetoplast (k) and nucleus (n). Merged DAPI/DIC images are presented on the left and merged three-channel fluorescence images are presented on the right. Note that no staining of untransfected (non-epitope-tagged) cells was detected under standard conditions with either anti-HA or anti-Ty antibodies (data not shown).
cell seen in Fig. 6I -L, both TbSLS4:HA and TbGT15:Ty presented as two discrete clusters that colocalized prominently in the post-nuclear region. These results indicate that endogenous TbSLS4 defines a discrete subcellular compartment synonymous with the Golgi apparatus in BSF trypanosomes.
TbSLS silencing disrupts post-nuclear ultrastructure
The role of TbSLS in maintenance of cellular ultrastructure was studied following specific silencing of the TbSLS locus. In control cells a pattern of internal structures was seen in the post-nuclear region, consistent with normal ER, lyso-endosomal and flagellar pocket membranes (Fig. 7A) . TbSLS ablation generated marked changes in the post-nuclear region that consistently presented as a severe but localized disruption of membrane morphology ( Fig. 7B-D) typified by large multilamellar whorls. No other obvious ultrastructural abnormalities were observed in TbSLS-silenced cells. This specific membrane disruption is likely due to depletion of TbSLS, and not a secondary effect due to cell death, as it was not observed following RNAi silencing of ornithine decarboxylase, an essential protein not involved in membrane trafficking and structure . These alterations may reflect disruption of the Golgi due to accumulation of ceramide, although other organelles in the post-nuclear region, such as the lysosome or endosomes, cannot be ruled out by these data.
TbSLS silencing has no effect on post-Golgi protein trafficking
Association of GPI-anchored proteins with sphingolipid/ cholesterol-rich microdomains influences apical targeting in polarized mammalian epithelial cells. Proper trafficking of GPI-anchored proteins in BSF trypanosomes is also critically dependent on the anchor itself (Schwartz and Bangs, 2006) . However, our work with pharmacological inhibitors indicates that de novo synthesis of long-chain sphingoid base is not essential for GPI-dependent trafficking in trypanosomes (Sutterwala et al., 2007) . Similarly, genetic disruption of sphingoid base synthesis in Leishmania has no overt effect on protein trafficking (Zhang et al., 2003) . To assess the role of higher-order sphingolipids in VSG transport we used an assay that relies on the differential susceptibility of mature surface VSG versus newly synthesized internal VSG to release by endogenous GPI-specific phospholipase C (GPI-PLC) (Bangs et al., 1986) . Susceptibility to GPI hydrolysis during hypotonic lysis coincides kinetically with the arrival of VSG at the cell surface (t1/2~15 min). As expected, newly synthesized VSG in control cells was resistant to release by hypotonic lysis (Fig. 8, lane 2) but became completely sensitive during the chase period (lanes 3-5). TbSLS silencing had no effect on the kinetics of VSG release (lanes 8-11), indicating that VSG trafficking is not dependent on de novo synthesis of higher-order sphingolipids. Additional trafficking assays indicated that delivery of two lysosomal marker proteins, soluble trypanopain and membrane-bound p67, were unaffected by TbSLS ablation (Fig. S5) . Importantly, extensive N-glycan processing of p67 was also unaffected. Collectively, these data indicate that short-term TbSLS ablation, despite having severe effects on post-nuclear morphology, does not impair N-glycan processing in the Golgi or subsequent post-Golgi trafficking of secretory or lysosomal cargo in BSF trypanosomes.
TbSLS structure
Our model for the kinetoplastid SLS proteins (Fig. 9A,  Fig. S1 ) differs from that of , which is based on single sequence analysis of L. major IPCS. They proposed a seven-TM topology with an extra helix (TMx) between TM3 and TM4, and with the orientation of the upstream TM1-3 inverted to preserve the critical lumenal positioning of the active-site catalytic triad in TM4 and TM6 as defined for yeast IPCS and human SMS2 (Levine et al., 2000; . Based on these features, and the apparent absence of the SM synthase D2 signature motif, Denny et al. proposed that the kinetoplastid enzymes comprise a novel group of SL synthases. However, there are grounds for a more cautious interpretation. First, all the kinetoplastid sequences do contain a conserved D2 motif correctly located in TM3 (Fig. 9B and Fig. S1 ). Second, the inversion of TM1-3 places both D1 and D2 in the wrong orientation relative to D3 and D4, which seems unlikely for conserved 'signature' motifs. Third, the proposed TMx is very short (11 residues), even for a Golgi protein, which typically have short-TM domains (Levine et al., 2000) . Our model is guided by that of for human SMS2, and is based on comparative alignment of single orthologous sequences from three kinetoplastid species, which is more predictive than single sequence analysis (Rost et al., 2004) . For each orf a seven-TM structure was ini- Fig. 8 . Effect of SLS silencing on forward secretory trafficking. Clonal bloodstream cells containing the TbSLS RNAi construct were cultured for 24 h without (-) or with (+) tetracycline to induce specific dsRNA synthesis. Cells were pulse-labelled for 5 min and at the indicated chase times aliquots were separated into cell and media fractions. VSG was immunoprecipitated from total cell extracts (Tot.) and released supernatants as indicated. The mobilities of VSG (V) and molecular mass standards (kDa) are noted. tially defined, with a cytosolic N-terminus and a lumenal C-terminus, but there are two ambiguities. First, as in the model of Denny et al. a TMx between TM3 and TM4 is predicted, albeit with marginal probabilities (Յ 0.55, maximum of 1.0) and short length (~11 residues) (see Fig. S1 ). Therefore we discount TMx, which restores the proper orientation of all downstream TM helices. Second, the entire region (~45 residues) spanning TM4 and TM5 is predicted to be membrane-associated, and consequently the positioning of the lumenal loop separating these TMs is subjective. We have chosen a position that preserves the position of the D3 motif and the catalytic His 210 residue near the lumenal side of the membrane. Thus, our model is fully consistent with the original model of for SMS2, and in the absence of more structural data we consider the kinetoplastid enzymes as more similar than not to other SM synthases.
Discussion
Trypanosome sphingolipids
Sphingolipids are essential structural components of biological membranes in all eukaryotes, and function in diverse cellular processes (Tafesse et al., 2006; Lahiri and Futerman, 2007) . In microbial pathogens sphingolipids have been studied with the aim of developing new chemotherapeutic targets; consequently there has been a tendency to contrast mammals, which synthesize SM, with fungi and kinetoplastids, which synthesize IPC (Denny and Smith, 2004; Heung et al., 2006; Sonda and Hehl, 2006) . This can be a useful simplification but it ignores the presence of glycosphingolipids in pathogenic fungi (Heung et al., 2006) , as well as African trypanosomes (Uemura et al., 2006) , and reports of SM in both T. brucei and T. cruzi (Patnaik et al., 1993; Quiñones et al., 2004) . Thus, trypanosomes offer a snapshot of sphingolipid diversity in unicellular eukaryotes. With this in mind we have performed a detailed study of phosphosphingolipids in T. brucei. In agreement with recent studies (Güther et al., 2006; Fridberg et al., 2008) , we find that PCF parasites contain IPCs centred on a major species of d18:0/16:0-IPC. We also establish for the first time that both life cycle stages actually synthesize SM, 1 but quite unexpectedly that BSF parasites do not contain detectable IPC. These novel findings indicate that sphingolipid synthesis is developmentally regulated in African trypanosomes. Another unexpected sphingolipid seen in our analyses is EPC, which is found in some insect and mammalian membranes (Tafesse et al., 2006) . This is the first report of EPC in kinetoplastid protozoa. Developmental variation in sphingolipid synthesis is also apparent in the dominant ceramide found in each stage of the trypanosome life cycle. Both contain d18:0/16:0 dihydroceramide and d18:1/16:0 ceramide, but the ratios are skewed towards dihydroceramide in PCF parasites and ceramide in BSF parasites, reflecting the composition of complex sphingolipids from each stage. It is likely that this bias is established by differential expression and/or regulation of dihydroceramide desaturase, the enzyme responsible for converting dihydroceramide to ceramide.
Trypanosome sphingolipid synthases
Because the TbSLS proteins are highly similar to the orthologous LmjIPCS, we initially assumed the TbSLS enzymes would also be IPC synthases. However, several observations suggest that they are primarily SM synthases. First, both the TbSLS and LmjIPCS proteins score highest for similarity to SM synthases from vertebrates and insects in reciprocal homology searches, but no similarity to the yeast IPC synthase is detected. Second, we predict both TbSLSs and LmjIPCS, as well as the T. cruzi orthologues, to closely fit the proposed SMS2 model , including the positions of the D1 and D2 SMS signature motifs, which are not found in yeast IPCS. Finally, TbSLS4 has authentic SMS activity when expressed in Leishmania, raising the possibility that all the TbSLS proteins are SM synthases. Extensive genetic and biochemical analyses will be required to validate such activity in the other TbSLS gene products, but consistent with this scenario is the extreme sequence conservation of the four TbSLS orfs. Significant heterogeneity is found only in the C-termini, which are topologically removed from the catalytic residues ( Fig. 9A and Fig. S1 ). Tellingly, TbSLS genes are constitutively expressed in both stages of the life cycle, and likewise SM is synthesized in both stages, while IPC is confined to PCF parasites. The structural determinants that favour transfer of phosphorylcholine by the T. brucei enzyme(s), and phosphorylinostol by the L. major enzyme, likely reside in amino acid differences found within the homologous lumenal loops that form the active sites of each protein.
This scenario begs the question of what enzyme(s) are responsible for stage-specific IPC synthesis in trypanosomes. Perhaps one or more of the TbSLS enzymes are sufficiently divergent to mediate IPC synthesis, or alternatively may be bi-functional for IPC synthesis. Both of these possibilities would require differential gene expression within the TbSLS locus to account for the stage-specific pattern of IPC synthesis. Our Northern analyses do not define the contribution of each orf to total 1 During final preparation of this manuscript for publication a separate report appeared demonstrating metabolic incorporation by procyclic trypanosomes of [ 3 H]-serine into a baseresistant lipid species with the chromatographic mobility of sphingomyelin (Signorell et al., 2008) . This finding also indicates the de novo synthesis of sphingomyelin by African trypanosomes.
TbSLS message levels, and more specific probes will be required to resolve this issue. Likewise, the endogenous IPC background in the transgenic L. major promastigotes prevents us from directly assaying for IPC synthesis, and ultimately it will be necessary to move the TbSLS genes into an appropriate IPC null background. However, an alternate possibility that must be considered is that other uncharacterized T. brucei gene product(s) function as IPC synthases.
An additional issue concerning TbSLS biosynthetic activity is the origin of EPC in BSF trypanosomes. EPC is synthesized in a manner analogous to SM synthesis, transfer of ethanolamine phosphate from phosphatidylethanolamine to ceramide (Malgat et al., 1986; Acharya and Acharya, 2005; Tafesse et al., 2006) , and the structural requirements for substrate recognition and phosphoryl transfer are likely to be very similar. Strikingly, EPC was found by ESI-MS in transgenic L. major (Table 1) suggesting that TbSLS4 is a bi-functional SM/EPC synthase, which has been postulated but not yet been demonstrated in any system Tafesse et al., 2006) . The absence of EPC in PCF total lipid profiles, and of NBD-EPC in biosynthesis assays, do not necessarily contradict this possibility. SM levels are lower in procyclics relative to other phospholipids, and by analogy to BSF lipid profiles the levels of EPC would be expected to be lower yet. Thus failure to detect EPC may simply be an issue of sensitivity. Likewise the lack of appropriate standards precludes identification of NBD-EPC in biosynthesis assays, but the uncharacterized BSF-specific product (Fig. 5A, asterisk) is a strong candidate for this species. Additional studies, including development of an in vitro assay similar to that used for LmjIPC synthase (see Fig. S4 ), will be required to resolve these issues, and to determine whether all four TbSLSs are capable of bi-functional SM/EPC synthesis. Finally, it is worth noting that compositional analyses of lipids from BSF trypanosomes also revealed the presence of low levels of dimethyl-EPC (Table 1) . EPC can be converted to SM in mammalian microsomal membranes by sequential methylation (Malgat et al., 1986) , and this pathway may operate in trypanosomes.
Sphingolipid requirements in trypanosomes
A major difference between sphingolipid metabolism in T. brucei and Leishmania is the need for de novo synthesis of sphingoid base as a precursor for higher-order sphingolipids. L. major promastigotes null for sevine palmitoyltransferase, the first enzyme of the sphingoid base pathway, are viable suggesting that Leishmania do not require sphingolipids per se (Zhang et al., 2003) . Rather they use sphingoid base to generate ethanolamine via sphingosine lyase for anabolic purposes . In contrast, African trypanosomes are critically dependent on de novo sphingoid base synthesis, and cannot be rescued by exogenous ethanolamine (Sutterwala et al., 2007) . Furthermore, our work indicates that TbSLS expression is essential for viability of BSF trypanosomes. They may also use sphingoid base to generate ethanolamine, but clearly ongoing synthesis of higherorder sphingolipids is critical for other cellular processes. However, several observations suggest that growth arrest of TbSLS ablated cells is not due to disruption of cellular membranes. BSF growth arrests rapidly following induction of silencing (~8 h), yet TbSLS mRNA levels are only reduced by~50% at 24 h with no obvious change in complex sphingolipids levels. Perhaps the modest reduction in TbSLS expression perturbs the balance of two key intracellular signalling molecules, ceramide and diacylglycerol (DAG), which are consumed and produced, respectively, by sphingolipid synthesis. In mammalian cells ceramide is generally pro-apototic (Lahiri and Futerman, 2007) , and DAG can be either pro-apototic or pro-survival depending on its interactions with protein kinase C isoforms (Griner and Kazanietz, 2007) . In Cryptococcus neoformans IPCS activity inversely affects DAG and phytoceramide levels resulting in regulation of virulence determinants (Shea and Del Poeta, 2006) . Silencing of TbSLS clearly elevates ceramide, and it is also possible that DAG levels are co-ordinately depressed. Such effects could account for rapid growth arrest via downstream mediators, but it still cannot be ruled out that trypanosomes also require complex sphingolipids for membrane integrity.
Issues arising
Our work has intriguing implications for the evolution of SL synthases, for their role in pathogenesis, and their potential as therapeutic targets. Sphingolipid synthases belong to the general class of lipid phosphate phosphatases (Tafesse et al., 2006) . Phylogenetic analyses indicates that LmjIPCS is more closely related to the other trypanosomal SLSs than to fungal IPC synthases , suggesting that the Leishmania enzyme diverged from an ancestral kinetoplastid SLS gene. This scenario is consistent with the chromosomal synteny of the kintoplastid genes. Thus it may be that eukaryotic IPC synthase activity has evolved at least twice -once in a protozoan lineage and containing all four SM signature motifs (D1-4), and once in a fungal lineage and containing only the D3 and D4 motifs.
Regarding pathogenesis, it is striking that of all the kinetoplastid parasites only bloodstream stage African trypanosomes synthesizes SM to the exclusion of IPC. Also one cannot ignore the obvious correlate that only this parasite lives extracellularly in the mammalian host. All other mammalian replicative stages of both Leishmania and T. cruzi are obligately intracellular. This is also a common theme with systemic fungal pathogens, which synthesize IPC not SM, and many of which replicate intracellularly (Heung et al., 2006) . Perhaps in order to avoid triggering host innate immune mechanisms trypanosomes restrict sphingolipid synthesis to SM, the major phosphosphingolipid of the mammalian host.
In summary, we have found multiple novel aspects of sphingolipid metabolism in trypanosomes. Unlike Leishmania, synthesis of higher-order sphingolipids is critical for African trypanosomes, validating the potential of this pathway as a target for drug development. The possibility that the TbSLS proteins may all be SM synthases notwithstanding, there may be sufficient differences from the mammalian enzymes to allow pharmacological discrimination. This alone is enough to warrant further investigation, but additionally the novelty of our findings challenges long-held assumptions about sphingolipid metabolism in unicellular eukaryotes, and answers to the remaining questions about biological function and biosynthetic specificity in African trypanosomes are sure to provide new insights.
Experimental procedures
Cell culture, metabolic labelling and immunoprecipitation
Standard propagation of BSF and PCF Lister 427 strain T. brucei brucei, and the derivative Lister 427 bloodstreamstage 13-90 cell line (Wirtz et al., 1999) is described elsewhere (Sutterwala et al., 2007; . Certified tetracycline-free FBS (Clonetech, Mountain View, CA) was used for the 13-90 cell line. L. major strain FV39 clone 5 (RHO/SU/59/P) promastigotes were maintained in M199 media with supplements and 10% FBS at 27°C. Metabolic radiolabelling and immunoprecipitation of cultured BSF trypanosomes were performed as described previously , as was analysis of VSG trafficking (Sutterwala et al., 2007) . All immunoprecipitates were fractionated by 10% SDS-PAGE, and gels were analysed by phosphorimaging using a Molecular Dynamics Typhoon Storm 860 system with native ImageQuant Software (Amersham Biosciences, Piscataway, NJ).
Plasmids, epitope tagging and cell lines
Templates for all PCR reactions were genomic DNA from either Lister 427 strain T. brucei or strain FV39 clone 5 L. major. To construct the TbSLS RNAi plasmid, a 746 nt section (nt 186-931) of the TbSLS1 orf (see Fig. 1A ) was generated from Lister 427 strain genomic DNA by PCR and placed into the BamHI/XhoI sites of p2T7Ti (LaCount et al., 2000) . The construct was linearized with NotI and introduced into 13-90 BSF cells by electroporation. Stable transformants were selected with phleomycin and the clonal TbSLS RNAi cell line was obtained by limiting dilution. Synthesis of dsRNA was induced by addition of tetracycline to 1 mg ml -1 . The TbSLS4 genomic orf was amplified by PCR with a Leishmania kozak-like sequence (CCACC) immediately preceding the start codon, and was inserted into the 'a' site of pIR1SAT using 5′ SmaI and 3′ XbaI sites (Robinson and Beverley, 2003) . Vector was linearized with SwaI and introduced into L. major FV39 clone 5 promastigotes by electroporation. Clonal stable integrative transformants were selected on semi-solid media with 100 mg ml -1 nourseothricin. Because the PCR primers were designed prior to discovering that an internal trans-splice site is utilized in the native TbSLS message (see Fig. 1B ), the amplicon contains 18 in-frame codons upstream of the native translational start site. RT-PCR with RNA from the Leishmania transformants confirmed the presence of these codons in the mRNA (see below), indicating that the native TbSLS trans-splice site is not used in Leishmania, and consequently that the heterologously expressed protein contains 18 N-terminal residues not found in the native protein. The L. major IPCS orf was amplified by PCR and inserted into the HindIII (5′) and EcoRI (3′) sites of pXS5 neo . The vector was linearized with BsmI, introduced into cultured Lister 427 BSF cells by electroporation and transformants were selected with G418 (5 mg ml -1 ). The TbSLS4 gene was in situ epitope tagged with a C-terminal HA tag (YPYDVPDYA) by targeted recombination (see Fig. 1A ). To construct the integration plasmid, a 583 nt section of the 3′ end of TbSLS4 with a fused 27 nt HA epitope sequence was generated by PCR and placed into the KpnI/ EcoRI sites of pXS5 neo . A 411 nt section from the immediate 3′ flanking sequence of TbSLS4 was also generated by PCR and placed into the PacI/SacI sites of the same plasmid. The resulting vector, containing the 3′ end of the TbSLS4 orf with an in-frame HA tag followed consecutively by the aldolase intragenic region, the neomycin resistance cassette and the 3′ UTR of TbSLS4, was cut with KpnI/SacI and stable transformants were generated as described above. In a similar manner the endogenous b-N-acetylglucosaminyl transferase gene TbGT15 (Tb927.7.300) was epitope tagged in situ with the Ty tag (EVHTNQDPLD) derived from the S. cerevisiae Ty-1 virus-like particle (Bastin et al., 1996) . The 30 nt Ty epitope sequence was fused by PCR to the 3′ end of a 453 nt section of the 3′ end of the TbGT15 gene, and was inserted into the HindIII/EcoRI sites of pXS5 pac . A 392 nt sequence from the immediate TbGT15 UTR was generated by PCR and inserted into the PacI/SacI sites of the same plasmid, which was then linearized with HindIII/SacI and used to transfect the TbSLS4:HA cell line. Correct in-frame fusions of both the TbSLS:HA and the TbGT15:Ty tags were confirmed by PCR from genomic DNA and sequencing (data not shown).
TbSLS 5Ј end mapping
Total RNA from Lister 427 strain T. brucei BSF cells was extracted using Tri Reagent (Molecular Research Center, Cincinati, OH). RT-PCR was performed with the Access RT-PCR System (Promega, Madison, WI). Specific RT-PCR primers were designed to the T. brucei mRNA 5′ spliced leader sequence (sense: 5′-CGCTATTATTAGAACAGTTTC TG-3′) and to a common internal TbSLS1-4 coding sequence (nt 572-587, antisense: 5′-CCAGCTGTAAGAACAG-3′). Control reactions were set up using either RNA alone, RNase-treated RNA, DNase-treated RNA or dH2O. PCR products from 500 ml of RT-PCR reactions were extracted with phenol/chloroform and re-suspended in 100 ml of dH2O.
Sequencing reactions were performed using primers to two common internal TbSLS1-4 coding sequences (nt 143-161, 5′-TCCGGCATACGTTCATGTG-3′; nt 289-306, 5′-CCGGT GAAGAAGGTACAG-3′). All sequences confirmed transplicing at nt -17 relative to the initiator methionine as shown in Fig. 1B . An analogous procedure was used to confirm the 5′ end of TbSLS4 expressed in L. major.
Analysis of lipids by mass spectrometry
Analytical tandem mass spectrometry methods and sphingolipid nomenclature have been described previously . Briefly, total lipids were extracted from cells using CMW (10:10:9) and blown to dryness under a stream of nitrogen. Samples were reconstituted in methanol before analysis with a Finnigan (San Jose, CA) Linear ion-trap (LIT) mass spectrometer (MS) with Xcalibur operating system. Sample solutions were continuously infused (2 ml min -1 ) to the electrospray ionization (ESI source, where the skimmer was set at ground potential, the electrospray needle was set at 4.5 kV and temperature of the heated capillary was 300°C. The automatic gain control of the ion trap was set to 5 ¥ 10 4 , with a maximum injection time of 100 ms. Helium was used as the buffer and collision gas at a pressure of 1 ¥ 10 -3 mbar (0.75 mTorr). The MS spectra were acquired using enhanced scan rate and accumulated in the profile mode, typically 2 min. The MS n (n = 2, 3, 4) experiments were carried out with an optimized relative collision energy ranging from 16% to 20% with an activation q-value at 0.25 and the activation time at 30-50 ms to leave a minimal residual abundance of precursor ion (around 20%). The MS n (n = 2, 3, 4) spectra were also acquired in profile mode and accumulated for 3-5 min. The mass resolution of the instrument was tuned to 0.6 Da at half peak height.
In vivo metabolism of fluorescent ceramide
Procyclic and bloodstream form trypanosomes, and Leishmania promastigotes, from log phase cultures were re-suspended at 5 ¥ 10 7 ml -1 in serum-free Cunningham's (procyclics), HMI9 (bloodstream forms) or M199 (promastigotes) media containing 5 mM NBD C6-ceramide complexed to BSA (Molecular Probes, Seattle, WA), and were incubated for 30 min on ice. Cells were then washed to remove free BSA : ceramide complex and incubated in serum-free media at 27°C (procyclics and promastigotes) or 37°C (bloodstream forms) for 60 min to allow metabolism of the fluorescent ceramide. Total lipids were extracted with CMW (10:10:3, v/v/v), dried under liquid N2, and subjected to n-butanol/water partitioning. Lipids recovered from the butanol phase were fractionated by thin-layer chromatography (TLC) in chloroform : methanol : ammonium hydroxide (65:25:4, v/v/v) on TLC Silica Gel 60 plates (Merck, Gibbsburg, NJ). Fluorescent lipids were visualized on a Storm 860 imaging system with ImageQuant software. For treatment with sphingomyelinase (Staphylococcus aureus, Sigma), lipids were scraped from the TLC plate, solubilized in chloroform : methanol (2:1) and dried under liquid N2. Samples were dissolved in 0.5 ml of 20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 0.05% NP-40 and incubated at 37°C for 30 min in a sonicating water bath to facilitate the formation of lipid micelles. Samples were incubated at 37°C for 2 h with or without 2.5 U of enzyme. Reactions were stopped and extracted by n-butanol/water partitioning. Similarly for treatment with PI-PLC scraped lipids were dissolved in 100 ml of 50 mM Tris-HCl, pH 7.4, 0.1% deoxycholate plus or minus enzyme (generously provided by Dr Anant Menon, Cornell Weill Medical College, New York). Samples were incubated at 37°C for 1 h, reactions were stopped by addition of 10 ml of acetic acid, and lipids were extracted by n-butanol/water partitioning. For both enzymatic treatment extracted lipids were fractionated by TLC in CMW (65:25:4, v/v/v) .
Antibodies
Rabbit anti-VSG221, rabbit anti-trypanopain and monoclonal anti-p67 (mAb 218) are described in and . Mouse anti-BiP was generated with recombinant protein. Other antibodies were rabbit anti-HA (Invitrogen, Carlsbad, CA), mouse anti-HA (Covance Research Products, Berkeley, CA) and monoclonal anti-Ty (UAB Hybridoma Facility, Birmingham, AL). Secondary reagents were from Molecular Probes (Seattle, WA).
Imaging
Washed bloodstream cells were fixed in PBS with 2% formaldehyde (2 ¥ 10 7 ml -1 , 5 min, 4°C) and then settled on poly-L-lysine slides (20 min, room temperature). Fixative was aspirated and slides were blocked (PBS, 10% goat serum). Slides were stained primary antibodies in blocking solution with 0.1% NP40, washed, and stained again with appropriate secondary antibodies and 500 ng ml -1 DAPI in blocking solution. Slides were mounted in PBS : glycerol (50:50). Images were acquired and deconvolved as described elsewhere . Single Z-plane images are presented unless stated otherwise. Transmission electron microscopy was performed as described previously (Sutterwala et al., 2007) .
Topology predictions
Multiple sequence alignment was performed in MacVector 9.0.2 software (MacVector, Cary, NC) and the PHD suite of algorithms (http://www.predictprotein.org) (Rost et al., 2004) was used for topology predictions. The TbSLS1, TcSLS1 and LmjIPCS proteins, GeneDB Accession No. Tb09.211.1030, Tc00.1047053506885.124 and LmjF35.4990, respectively (http://www.genedb.org), were aligned in multiple submission format and topologies predicted for each protein (see Fig. 9 and Fig. S1 ). Use of a single orthologue from each species increases the accuracy of the overall predictions while giving equal weight to each species. The boundaries for each predicted TM helix were manually adjusted for the each sequence using the conserved signature SM synthase domains and predicted topology of human SMS2 as a reference tetracycline to induce specific dsRNA synthesis. Cells were pulse radiolabeled for 15 minutes and chased as indicated. The fates of endogenous lysosomal markers were followed by specific immunoprecipitation, SDS-PAGE, and phosphorimaging. A. Transport and proteolytic turnover of the lysosomal membrane protein p67. Normal p67 trafficking involves synthesis of an ER gp100 glycoform, which is converted to gp150 by N-glycan processing in the Golgi, and is subsequently fragmented (gp75, gp42, gp32) upon arrival in the lysosome . B. Transport and proteolytic activation of the lumenal lysosomal protease trypanopain. Normal trypanopain trafficking involves synthesis of an ER precursor (P), which is activated to a mature form (M) by proteolytic removal of a prodomain in the lysososme . TbSLS1 silencing had no effect on the processing or transport of either p67 or trypanopain. 
